Dragonfly Therapeutics, Inc.

Organization

Cambridge, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 11,939,384
- Issue date Mar 26, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 11,884,733
- Issue date Jan 30, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins binding HER2, NKG2D and CD16
- Patent number 11,884,732
- Issue date Jan 30, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-...
- Patent number 11,834,506
- Issue date Dec 5, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric Fc-fused proteins
- Patent number 11,787,864
- Issue date Oct 17, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES TARGETING FLT3 AND USE THEREOF
- Publication number 20240132598
- Publication date Apr 25, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16, AND CEACAM5
- Publication number 20240124607
- Publication date Apr 18, 2024
- Merck Sharp & Dohme LLC
- Amy M. Beebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND FLT3
- Publication number 20240117054
- Publication date Apr 11, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240076385
- Publication date Mar 7, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240076384
- Publication date Mar 7, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240067735
- Publication date Feb 29, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING CD123, NKG2D AND CD16
- Publication number 20240018266
- Publication date Jan 18, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS TH...
- Publication number 20230416402
- Publication date Dec 28, 2023
- Dragonfly Therapeutics, Inc.
- Jean-Marie Cuillerot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC BINDING PROTEINS TARGETING CEA
- Publication number 20230391877
- Publication date Dec 7, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND NECTIN4
- Publication number 20230357409
- Publication date Nov 9, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230303702
- Publication date Sep 28, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING EGFR AND USE THEREOF
- Publication number 20230279121
- Publication date Sep 7, 2023
- Dragonfly Therapeutics, Inc.
- Asya Grinberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Formulation, Dosage Regimen, and Manufacturing Process for Heterodi...
- Publication number 20230272041
- Publication date Aug 31, 2023
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND EGFR
- Publication number 20230257467
- Publication date Aug 17, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PPHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC...
- Publication number 20230250176
- Publication date Aug 10, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230227562
- Publication date Jul 20, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Targeting CLEC12A and Use Thereof
- Publication number 20230220084
- Publication date Jul 13, 2023
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES TARGETING 5T4 AND USES THEREOF
- Publication number 20230220106
- Publication date Jul 13, 2023
- Dragonfly Therapeutics, Inc.
- Pyae P. Hein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND 5T4
- Publication number 20230203202
- Publication date Jun 29, 2023
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC FC-FUSED PROTEINS
- Publication number 20230033425
- Publication date Feb 2, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS TH...
- Publication number 20230034186
- Publication date Feb 2, 2023
- Dragonfly Therapeutics, Inc.
- Jean-Marie Cuillerot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...
- Publication number 20220380459
- Publication date Dec 1, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR MULTI-SPECIFIC...
- Publication number 20220195065
- Publication date Jun 23, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN
- Publication number 20220153848
- Publication date May 19, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND CLEC12A
- Publication number 20220119534
- Publication date Apr 21, 2022
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC FC-FUSED PROTEINS
- Publication number 20220119533
- Publication date Apr 21, 2022
- Dragonfly Therapeutics, Inc.
- Ann F. CHEUNG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...
- Publication number 20220089760
- Publication date Mar 24, 2022
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING DLL3, AND USE THEREOF
- Publication number 20220025037
- Publication date Jan 27, 2022
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEIN BINDING NKG2D, CD16 AND A FIBROBLAST ACTIVATION PROTEIN
- Publication number 20210363261
- Publication date Nov 25, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...
- Publication number 20210317223
- Publication date Oct 14, 2021
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
90165665 - TRINKET
- Serial number 90165665
- Registration number 6986954
- Filing date Sep 8, 2020
- Dragonfly Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88891086 - PINPOINT
- Serial number 88891086
- Filing date Apr 28, 2020
- Dragonfly Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87296912 - TRINKET
- Serial number 87296912
- Filing date Jan 11, 2017
- Dragonfly Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87092750 - DRAGONFLY THERAPEUTICS
- Serial number 87092750
- Registration number 5272538
- Filing date Jul 5, 2016
- Equipoise Therapeutics Corporation
- 42 - Scientific and technological services and research and design relating thereto

Dragonfly Therapeutics, Inc.

Organization

Patents Grantslast 30 patents

Antibody variable domains targeting the NKG2D receptor

Antibody variable domains targeting the NKG2D receptor

Proteins binding HER2, NKG2D and CD16

Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-...

Heterodimeric Fc-fused proteins

Patents Applicationslast 30 patents

ANTIBODIES TARGETING FLT3 AND USE THEREOF

PROTEINS BINDING NKG2D, CD16, AND CEACAM5

PROTEINS BINDING NKG2D, CD16 AND FLT3

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

PROTEINS BINDING CD123, NKG2D AND CD16

METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS TH...

MULTISPECIFIC BINDING PROTEINS TARGETING CEA

PROTEINS BINDING NKG2D, CD16 AND NECTIN4

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

ANTIBODIES TARGETING EGFR AND USE THEREOF

Formulation, Dosage Regimen, and Manufacturing Process for Heterodi...

PROTEINS BINDING NKG2D, CD16 AND EGFR

PPHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC...

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

Antibodies Targeting CLEC12A and Use Thereof

ANTIBODIES TARGETING 5T4 AND USES THEREOF

PROTEINS BINDING NKG2D, CD16 AND 5T4

HETERODIMERIC FC-FUSED PROTEINS

METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS TH...

MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...

PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR MULTI-SPECIFIC...

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

PROTEINS BINDING NKG2D, CD16 AND CLEC12A

HETERODIMERIC FC-FUSED PROTEINS

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...

ANTIBODY VARIABLE DOMAINS TARGETING DLL3, AND USE THEREOF

PROTEIN BINDING NKG2D, CD16 AND A FIBROBLAST ACTIVATION PROTEIN

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...

Trademarklast 30 trademarks

90165665 - TRINKET

88891086 - PINPOINT

87296912 - TRINKET

87092750 - DRAGONFLY THERAPEUTICS